Question 1

What types of cancer are eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

Question 2

How does REGN1400 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of REGN1400 and the other drugs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the trial in terms of tests and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer clinical trial (NCT01727869). Contact the study team or your healthcare provider for specific answers.

What this study is about